Previous close | 5.0300 |
Open | 4.9100 |
Bid | 5.4400 x 900 |
Ask | 5.6700 x 1100 |
Day's range | 4.9000 - 4.9100 |
52-week range | 4.0200 - 7.3200 |
Volume | |
Avg. volume | 8,150 |
Market cap | 66.61M |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7200 |
Earnings date | 14 Mar 2024 - 18 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.00 |
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript March 12, 2024 Champions Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2024 Earnings Call. At this time all […]
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript December 12, 2023 Champions Oncology, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.17. Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note, this conference […]